rhMG53 decreases membrane damage <i>in vitro</i>. by Brian J. Paleo (8694246)

Line graph of estimated probability of silicosis in increasing categories of 0.5 mg/m3-years at varying associations of cumulative RCS exposure and silicosis. by Patrick Howlett (2612374)

Subjects:

Hypothesis that explains and predicts expansion of ages of KD due to decreased IgG levels. by Hiromi Yamaguchi (2396248)

Subjects:

The data of meta-analysis. by Fei Lin (156666)

Subjects:

Quality assessment for risk of bias for studies. by Fei Lin (156666)

Subjects:

Effect of tirzepatide vs placebo on body weight. by Fei Lin (156666)

Subjects:

The results of safety in meta-analysis. by Fei Lin (156666)

Subjects:

Graphs of risk of bias for studies. by Fei Lin (156666)

Subjects:

General baseline of included studies. by Fei Lin (156666)

Subjects:

Anti-TNF Thioester Glucocorticoid Antibody–Drug Conjugate Fully Inhibits Inflammation with Minimal Effect on Systemic Corticosterone Levels in a Mouse Arthritis Model by Christopher C. Marvin (1338228)

Subjects:

Anti-TNF Thioester Glucocorticoid Antibody–Drug Conjugate Fully Inhibits Inflammation with Minimal Effect on Systemic Corticosterone Levels in a Mouse Arthritis Model by Christopher C. Marvin (1338228)

Subjects:

Effects of H5 (20 and 40 mg/kg, p.o.), and diazepam (2.5 mg/kg, i.p.) in the Rota-rod test in mice. by Maria Alice Miranda Bezerra Medeiros (11752002)

The injectable contraceptives depot medroxyprogesterone acetate and norethisterone enanthate substantially and differentially decrease testosterone and sex hormone binding globulin... by Chanel Avenant (409756)

“…Both contraceptives substantially decreased, from D0 to 25W, the total testosterone [DMPA-IM D0 0.560, 25W 0.423 nmol/L, -24.3% (p < 0.0001); NET-EN D0 0.551, 25W 0.253 nmol/L, -54.1%, (p < 0.0001)], SHBG [DMPA-IM D0 45.0, 25W 32.7 nmol/L, -29.8% (p < 0.0001); NET-EN D0 50.2, 25W 17.6 nmol/L, -65.1% (p < 0.0001)], and calculated free testosterone levels [DMPA-IM D0 6.87, 25W 5.38 pmol/L, -17.2% (p = 0.0371); NET-EN D0 6.00, 25W 3.70, -40.0% (p < 0.0001)]. …”

Adverse events in low-dose naltrexone arm. by Judith I. Tsui (5983160)

Subjects:

CONSORT flow diagram. by Judith I. Tsui (5983160)

Subjects:

Adverse events in placebo arm. by Judith I. Tsui (5983160)

Subjects:

Adverse events in gabapentin arm. by Judith I. Tsui (5983160)

Subjects:

Design, Synthesis, and Biological Evaluation of [1,2,5]Oxadiazolo[3,4‑<i>b</i>]pyridin-7-ol as Mitochondrial Uncouplers for the Treatment of Obesity and Metabolic Dysfunction-Assoc... by Mary A. Foutz (20361830)

“…Mitochondrial uncouplers such as BAM15 increase respiration and energy expenditure and have potential in treating a variety of metabolic diseases. In this study, we disclose the structure–activity relationship profile of 6-substituted [1,2,5]oxadiazolo[3,4-<i>b</i>]pyridin-7-ol derivatives of BAM15. …”

Cell proliferation was decreased more by combination treatment of SLCP and BBR than individual treatments. by Panchanan Maiti (1459852)

Firing rates of PNs (as maximum activity) in response to a single synchronous triangular pulse of 50 ms duration applied to both ORN groups. by Mario Pannunzi (553941)